L-Loc Injection

ਉਤਪਾਦ ਝਲਕ

About L-Loc Injection

L-Loc Injection is a medication containing the active ingredient Terlipressin, classified as Vasopressin Receptor Agonist. Terlipressin, sold under the brand name Terlivaz among others, is an analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help. Terlipressin is a vasopressin receptor agonist.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE TERLIVAZ is indicated to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function
• Used for: Limitation of Use Patients with a serum creatinine > /dL are unlikely to experience benefit
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Terlipressin, the active ingredient in L-Loc Injection, belongs to the Vasopressin Receptor Agonist class. 1 INDICATIONS AND USAGE TERLIVAZ is indicated to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function. Limitation of Use Patients with a serum creatinine > /dL are unlikely to experience benefit. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking L-Loc Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use L-Loc Injection for extended periods without medical advice.